Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning.

Sotirchos ES, Filippatou A, Fitzgerald KC, Salama S, Pardo S, Wang J, Ogbuokiri E, Cowley NJ, Pellegrini N, Murphy OC, Mealy MA, Prince JL, Levy M, Calabresi PA, Saidha S.

Mult Scler. 2019 Jul 31:1352458519864928. doi: 10.1177/1352458519864928. [Epub ahead of print]

PMID:
31364464
2.

The prevalence and utility of screening for urinary tract infection at the time of presumed multiple sclerosis relapse.

Fitzgerald KC, Cassard LA, Fox SR, Probasco JC, Cassard SD, Mowry EM.

Mult Scler Relat Disord. 2019 Jul 2;35:61-66. doi: 10.1016/j.msard.2019.06.038. [Epub ahead of print]

PMID:
31344604
3.

DeepHarmony: A deep learning approach to contrast harmonization across scanner changes.

Dewey BE, Zhao C, Reinhold JC, Carass A, Fitzgerald KC, Sotirchos ES, Saidha S, Oh J, Pham DL, Calabresi PA, van Zijl PCM, Prince JL.

Magn Reson Imaging. 2019 Jul 10. pii: S0730-725X(18)30649-0. doi: 10.1016/j.mri.2019.05.041. [Epub ahead of print]

PMID:
31301354
4.

Early complement genes are associated with visual system degeneration in multiple sclerosis.

Fitzgerald KC, Kim K, Smith MD, Aston SA, Fioravante N, Rothman AM, Krieger S, Cofield SS, Kimbrough DJ, Bhargava P, Saidha S, Whartenby KA, Green AJ, Mowry EM, Cutter GR, Lublin FD, Baranzini SE, De Jager PL, Calabresi PA.

Brain. 2019 Sep 1;142(9):2722-2736. doi: 10.1093/brain/awz188.

PMID:
31289819
5.

Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis.

Fitzgerald KC, Salter A, Tyry T, Fox RJ, Cutter G, Marrie RA.

Mult Scler. 2019 May 13:1352458519845836. doi: 10.1177/1352458519845836. [Epub ahead of print]

PMID:
31079537
6.

Retinal measurements predict 10-year disability in multiple sclerosis.

Rothman A, Murphy OC, Fitzgerald KC, Button J, Gordon-Lipkin E, Ratchford JN, Newsome SD, Mowry EM, Sotirchos ES, Syc-Mazurek SB, Nguyen J, Caldito NG, Balcer LJ, Frohman EM, Frohman TC, Reich DS, Crainiceanu C, Saidha S, Calabresi PA.

Ann Clin Transl Neurol. 2019 Jan 19;6(2):222-232. doi: 10.1002/acn3.674. eCollection 2019 Feb.

7.

Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis.

Sotirchos ES, Gonzalez-Caldito N, Dewey BE, Fitzgerald KC, Glaister J, Filippatou A, Ogbuokiri E, Feldman S, Kwakyi O, Risher H, Crainiceanu C, Pham DL, Van Zijl PC, Mowry EM, Reich DS, Prince JL, Calabresi PA, Saidha S.

Mult Scler. 2019 Feb 11:1352458519826364. doi: 10.1177/1352458519826364. [Epub ahead of print]

PMID:
30741108
8.

Reporting of R2 Statistics for Mixed-Effects Regression Models.

Sotirchos ES, Fitzgerald KC, Crainiceanu CM.

JAMA Neurol. 2019 Apr 1;76(4):507. doi: 10.1001/jamaneurol.2018.4720. No abstract available.

PMID:
30715077
9.

Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes.

Fitzgerald KC, Salter A, Tyry T, Fox RJ, Cutter G, Mowry EM, Marrie RA.

Mult Scler Relat Disord. 2019 Apr;29:86-93. doi: 10.1016/j.msard.2019.01.031. Epub 2019 Jan 24.

PMID:
30690340
10.

Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes.

Bhargava P, Fitzgerald KC, Venkata SLV, Smith MD, Kornberg MD, Mowry EM, Haughey NJ, Calabresi PA.

Ann Clin Transl Neurol. 2018 Oct 30;6(1):33-45. doi: 10.1002/acn3.676. eCollection 2019 Jan.

11.

Pseudobulbar affect: Prevalence and association with symptoms in multiple sclerosis.

Fitzgerald KC, Salter A, Tyry T, Fox RJ, Cutter G, Marrie RA.

Neurol Clin Pract. 2018 Dec;8(6):472-481. doi: 10.1212/CPJ.0000000000000523.

PMID:
30588376
12.

Alu insertion variants alter mRNA splicing.

Payer LM, Steranka JP, Ardeljan D, Walker J, Fitzgerald KC, Calabresi PA, Cooper TA, Burns KH.

Nucleic Acids Res. 2019 Jan 10;47(1):421-431. doi: 10.1093/nar/gky1086.

13.

Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.

Caldito NG, Saidha S, Sotirchos ES, Dewey BE, Cowley NJ, Glaister J, Fitzgerald KC, Al-Louzi O, Nguyen J, Rothman A, Ogbuokiri E, Fioravante N, Feldman S, Kwakyi O, Risher H, Kimbrough D, Frohman TC, Frohman E, Balcer L, Crainiceanu C, Van Zijl PCM, Mowry EM, Reich DS, Oh J, Pham DL, Prince J, Calabresi PA.

Brain. 2018 Nov 1;141(11):3115-3129. doi: 10.1093/brain/awy245.

PMID:
30312381
14.

Effect of intermittent vs. daily calorie restriction on changes in weight and patient-reported outcomes in people with multiple sclerosis.

Fitzgerald KC, Vizthum D, Henry-Barron B, Schweitzer A, Cassard SD, Kossoff E, Hartman AL, Kapogiannis D, Sullivan P, Baer DJ, Mattson MP, Appel LJ, Mowry EM.

Mult Scler Relat Disord. 2018 Jul;23:33-39. doi: 10.1016/j.msard.2018.05.002. Epub 2018 May 5.

15.

A survey of dietary characteristics in a large population of people with multiple sclerosis.

Fitzgerald KC, Tyry T, Salter A, Cofield SS, Cutter G, Fox RJ, Marrie RA.

Mult Scler Relat Disord. 2018 May;22:12-18. doi: 10.1016/j.msard.2018.02.019. Epub 2018 Feb 27.

PMID:
29510324
16.

Diet quality is associated with disability and symptom severity in multiple sclerosis.

Fitzgerald KC, Tyry T, Salter A, Cofield SS, Cutter G, Fox R, Marrie RA.

Neurology. 2018 Jan 2;90(1):e1-e11. doi: 10.1212/WNL.0000000000004768. Epub 2017 Dec 6.

PMID:
29212827
17.

Clinical biomarkers differentiate myelitis from vascular and other causes of myelopathy.

Barreras P, Fitzgerald KC, Mealy MA, Jimenez JA, Becker D, Newsome SD, Levy M, Gailloud P, Pardo CA.

Neurology. 2018 Jan 2;90(1):e12-e21. doi: 10.1212/WNL.0000000000004765. Epub 2017 Dec 1.

18.

Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation.

Bhargava P, Fitzgerald KC, Calabresi PA, Mowry EM.

JCI Insight. 2017 Oct 5;2(19). pii: 95302. doi: 10.1172/jci.insight.95302.

19.

Reply to "Stratified analyses are necessary to verify the influence of salt intake in multiple sclerosis".

Fitzgerald KC, Munger KL, Ascherio A.

Ann Neurol. 2017 Oct;82(4):649. doi: 10.1002/ana.25055. Epub 2017 Oct 10. No abstract available.

PMID:
28961335
20.

Exposure to particulate matter air pollution and risk of multiple sclerosis in two large cohorts of US nurses.

Palacios N, Munger KL, Fitzgerald KC, Hart JE, Chitnis T, Ascherio A, Laden F.

Environ Int. 2017 Dec;109:64-72. doi: 10.1016/j.envint.2017.07.013. Epub 2017 Sep 20.

PMID:
28938101
21.

Air Pollution and Risk of Parkinson's Disease in a Large Prospective Study of Men.

Palacios N, Fitzgerald KC, Hart JE, Weisskopf M, Schwarzschild MA, Ascherio A, Laden F.

Environ Health Perspect. 2017 Aug 18;125(8):087011. doi: 10.1289/EHP259.

22.

Effects of an Extreme Flood on Trace Elements in River Water-From Urban Stream to Major River Basin.

Barber LB, Paschke SS, Battaglin WA, Douville C, Fitzgerald KC, Keefe SH, Roth DA, Vajda AM.

Environ Sci Technol. 2017 Sep 19;51(18):10344-10356. doi: 10.1021/acs.est.7b01767. Epub 2017 Sep 1.

PMID:
28862461
23.

Sodium intake and multiple sclerosis activity and progression in BENEFIT.

Fitzgerald KC, Munger KL, Hartung HP, Freedman MS, Montalbán X, Edan G, Wicklein EM, Radue EW, Kappos L, Pohl C, Ascherio A; BENEFIT Study Group.

Ann Neurol. 2017 Jul;82(1):20-29. doi: 10.1002/ana.24965.

24.

How global MS prevalence is changing: A retrospective chart review in the United Arab Emirates.

Schiess N, Huether K, Fatafta T, Fitzgerald KC, Calabresi PA, Blair I, Alsaadi T, Szolics M.

Mult Scler Relat Disord. 2016 Sep;9:73-9. doi: 10.1016/j.msard.2016.07.005. Epub 2016 Jul 7.

PMID:
27645349
25.

Hormone therapy use and physical quality of life in postmenopausal women with multiple sclerosis.

Bove R, White CC, Fitzgerald KC, Chitnis T, Chibnik L, Ascherio A, Munger KL.

Neurology. 2016 Oct 4;87(14):1457-1463. Epub 2016 Sep 7.

26.

Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis.

Kim SA, Inamura K, Yamauchi M, Nishihara R, Mima K, Sukawa Y, Li T, Yasunari M, Morikawa T, Fitzgerald KC, Fuchs CS, Wu K, Chan AT, Zhang X, Ogino S, Qian ZR.

Br J Cancer. 2016 Jan 19;114(2):199-206. doi: 10.1038/bjc.2015.347. Epub 2016 Jan 7.

27.

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.

Fitzgerald KC, Munger KL, Köchert K, Arnason BG, Comi G, Cook S, Goodin DS, Filippi M, Hartung HP, Jeffery DR, O'Connor P, Suarez G, Sandbrink R, Kappos L, Pohl C, Ascherio A.

JAMA Neurol. 2015 Dec;72(12):1458-65. doi: 10.1001/jamaneurol.2015.2742.

PMID:
26458124
28.

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.

Munger KL, Fitzgerald KC, Freedman MS, Hartung HP, Miller DH, Montalbán X, Edan G, Barkhof F, Suarez G, Radue EW, Sandbrink R, Kappos L, Pohl C, Ascherio A.

Neurology. 2015 Nov 10;85(19):1694-701. doi: 10.1212/WNL.0000000000002099. Epub 2015 Oct 9.

29.

Suburbanization, estrogen contamination, and sex ratio in wild amphibian populations.

Lambert MR, Giller GS, Barber LB, Fitzgerald KC, Skelly DK.

Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11881-6. doi: 10.1073/pnas.1501065112. Epub 2015 Sep 8.

30.

Impact of wastewater infrastructure upgrades on the urban water cycle: Reduction in halogenated reaction byproducts following conversion from chlorine gas to ultraviolet light disinfection.

Barber LB, Hladik ML, Vajda AM, Fitzgerald KC, Douville C.

Sci Total Environ. 2015 Oct 1;529:264-74. doi: 10.1016/j.scitotenv.2015.04.112. Epub 2015 May 27.

PMID:
26025637
31.

Proceedings of the second international molecular pathological epidemiology (MPE) meeting.

Ogino S, Campbell PT, Nishihara R, Phipps AI, Beck AH, Sherman ME, Chan AT, Troester MA, Bass AJ, Fitzgerald KC, Irizarry RA, Kelsey KT, Nan H, Peters U, Poole EM, Qian ZR, Tamimi RM, Tchetgen Tchetgen EJ, Tworoger SS, Zhang X, Giovannucci EL, van den Brandt PA, Rosner BA, Wang M, Chatterjee N, Begg CB.

Cancer Causes Control. 2015 Jul;26(7):959-72. doi: 10.1007/s10552-015-0596-2. Epub 2015 May 9.

32.

Intakes of caffeine, coffee and tea and risk of amyotrophic lateral sclerosis: Results from five cohort studies.

Fondell E, O'Reilly ÉI, Fitzgerald KC, Falcone GJ, Kolonel LN, Park Y, Gapstur SM, Ascherio A.

Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5-6):366-71. doi: 10.3109/21678421.2015.1020813. Epub 2015 Mar 30.

33.

Particulate matter and risk of Parkinson disease in a large prospective study of women.

Palacios N, Fitzgerald KC, Hart JE, Weisskopf MG, Schwarzschild MA, Ascherio A, Laden F.

Environ Health. 2014 Oct 7;13:80. doi: 10.1186/1476-069X-13-80.

34.

Dietary ω-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis.

Fitzgerald KC, O'Reilly ÉJ, Falcone GJ, McCullough ML, Park Y, Kolonel LN, Ascherio A.

JAMA Neurol. 2014 Sep;71(9):1102-10. doi: 10.1001/jamaneurol.2014.1214.

35.

Predicted 25(OH)D score and colorectal cancer risk according to vitamin D receptor expression.

Jung S, Qian ZR, Yamauchi M, Bertrand KA, Fitzgerald KC, Inamura K, Kim SA, Mima K, Sukawa Y, Zhang X, Wang M, Smith-Warner SA, Wu K, Fuchs CS, Chan AT, Giovannucci EL, Ng K, Cho E, Ogino S, Nishihara R.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1628-37. doi: 10.1158/1055-9965.EPI-14-0229. Epub 2014 Jun 11.

36.

Dietary fiber and amyotrophic lateral sclerosis: results from 5 large cohort studies.

Fondell E, O'Reilly EJ, Fitzgerald KC, Falcone GJ, Kolonel LN, Park Y, McCullough ML, Ascherio A.

Am J Epidemiol. 2014 Jun 15;179(12):1442-9. doi: 10.1093/aje/kwu089. Epub 2014 May 9.

37.

Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation.

Sandhu RK, Conen D, Tedrow UB, Fitzgerald KC, Pradhan AD, Ridker PM, Glynn RJ, Albert CM.

J Am Heart Assoc. 2014 May 1;3(3):e000916. doi: 10.1161/JAHA.114.000916.

38.

Early-onset alopecia and amyotrophic lateral sclerosis: a cohort study.

Fondell E, Fitzgerald KC, Falcone GJ, O'Reilly EJ, Ascherio A.

Am J Epidemiol. 2013 Oct 1;178(7):1146-9. doi: 10.1093/aje/kwt096. Epub 2013 Aug 13.

39.

Magnesium intake and risk of amyotrophic lateral sclerosis: results from five large cohort studies.

Fondell E, O'Reilly EJ, Fitzgerald KC, Falcone GJ, McCullough ML, Park Y, Kolonel LN, Ascherio A.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 Sep;14(5-6):356-61. doi: 10.3109/21678421.2013.803577. Epub 2013 Jun 18.

40.

Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: pooled results from 5 cohort studies.

Fitzgerald KC, O'Reilly ÉJ, Fondell E, Falcone GJ, McCullough ML, Park Y, Kolonel LN, Ascherio A.

Ann Neurol. 2013 Feb;73(2):236-45. doi: 10.1002/ana.23820. Epub 2013 Jan 29.

41.

Smoking, smoking cessation, and risk of sudden cardiac death in women.

Sandhu RK, Jimenez MC, Chiuve SE, Fitzgerald KC, Kenfield SA, Tedrow UB, Albert CM.

Circ Arrhythm Electrophysiol. 2012 Dec;5(6):1091-7. doi: 10.1161/CIRCEP.112.975219. Epub 2012 Dec 11.

42.

Premorbid body mass index and risk of amyotrophic lateral sclerosis.

O'Reilly ÉJ, Wang H, Weisskopf MG, Fitzgerald KC, Falcone G, McCullough ML, Thun M, Park Y, Kolonel LN, Ascherio A.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 Apr;14(3):205-11. doi: 10.3109/21678421.2012.735240. Epub 2012 Oct 29.

43.

Non-steroidal anti-inflammatory drugs and amyotrophic lateral sclerosis: results from five prospective cohort studies.

Fondell E, O'Reilly ÉJ, Fitzgerald KC, Falcone GJ, McCullough ML, Thun MJ, Park Y, Kolonel LN, Ascherio A.

Amyotroph Lateral Scler. 2012 Oct;13(6):573-9. doi: 10.3109/17482968.2012.703209. Epub 2012 Aug 7.

44.

Comparison of associations of adherence to a Dietary Approaches to Stop Hypertension (DASH)-style diet with risks of cardiovascular disease and venous thromboembolism.

Fitzgerald KC, Chiuve SE, Buring JE, Ridker PM, Glynn RJ.

J Thromb Haemost. 2012 Feb;10(2):189-98. doi: 10.1111/j.1538-7836.2011.04588.x.

45.

Epilepsy in children with delayed presentation of perinatal stroke.

Fitzgerald KC, Williams LS, Garg BP, Golomb MR.

J Child Neurol. 2007 Nov;22(11):1274-80.

PMID:
18006956
46.

Neonatal arterial ischemic stroke and sinovenous thrombosis associated with meningitis.

Fitzgerald KC, Golomb MR.

J Child Neurol. 2007 Jul;22(7):818-22.

PMID:
17715272
47.

Cerebral sinovenous thrombosis in the neonate.

Fitzgerald KC, Williams LS, Garg BP, Carvalho KS, Golomb MR.

Arch Neurol. 2006 Mar;63(3):405-9.

PMID:
16533968
48.

Professional autonomy in the practice of pharmacy.

Sawyer WT, Seward PA, Fitzgerald KC.

Top Hosp Pharm Manage. 1990 Feb;9(4):12-9. No abstract available.

PMID:
10128548
49.

Revisiting sex differences in the expression of depression.

Funabiki D, Bologna NC, Pepping M, FitzGerald KC.

J Abnorm Psychol. 1980 Apr;89(2):194-202. No abstract available.

PMID:
7365131

Supplemental Content

Loading ...
Support Center